Quarterly Consolidated Statement Of Cash Flows

Delta-Fly Pharma, Inc. - Filing #7710878

Concept As at
2019-03-31
2018-04-01 to
2019-03-31
As at
2018-03-31
2017-04-01 to
2018-03-31
As at
2017-03-31
Quarterly consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
-545,142,000 JPY
126,756,000 JPY
Interest paid
-318,000 JPY
-412,000 JPY
Income taxes paid
-1,394,000 JPY
-26,490,000 JPY
Net cash provided by (used in) operating activities
-585,385,000 JPY
100,042,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-1,818,000 JPY
JPY
Other, net
-1,726,000 JPY
JPY
Net cash provided by (used in) investing activities
-3,544,000 JPY
JPY
Cash flows from financing activities
Repayments of long-term borrowings
-6,792,000 JPY
-6,226,000 JPY
Proceeds from issuance of shares
3,339,956,000 JPY
298,950,000 JPY
Net cash provided by (used in) financing activities
3,316,882,000 JPY
292,724,000 JPY
Effect of exchange rate change on cash and cash equivalents
-765,000 JPY
598,000 JPY
Net increase (decrease) in cash and cash equivalents
2,727,186,000 JPY
393,365,000 JPY
Cash and cash equivalents
3,508,437,000 JPY
781,250,000 JPY
387,885,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.